Re-Vana Therapeutics

Barnes & Thornburg Advises Re-Vana Therapeutics on Strategic Collaboration with Boehringer Ingelheim

A cross-border partnership aims to accelerate long-acting ocular therapies and improve outcomes for patients with retinal disease.